[{"Assets_0_Q2_USD":363513000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-117721000.0,"NetIncomeLoss_1_Q2_USD":-35059000.0,"NetIncomeLoss_2_Q2_USD":-69950000.0,"StockholdersEquity_0_Q2_USD":106313000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170801"}]